Showing 1,661 - 1,680 results of 2,406 for search '"SARS"', query time: 0.07s Refine Results
  1. 1661

    Development and validation of a portable device for lab-free versatile nucleic acid extraction by Anthony J. Politza, Tianyi Liu, Aneesh Kshirsagar, Ming Dong, Md. Ahasan Ahamed, Weihua Guan

    Published 2024-10-01
    “…We evaluated our device, comparing our results against those from a benchtop centrifuge across three types of samples: HIV RNA in buffer, HIV RNA in plasma, and SARS-CoV-2 RNA in saliva. The portable device demonstrated excellent agreement with the benchtop centrifuge, indicating high reliability. …”
    Get full text
    Article
  2. 1662

    Impact of the Contamination Method on the Disinfection of N95 Respirators: Drops versus Aerosols by Mirna Alameddine, Oluchi Okoro, Loïc Wingert, Geneviève Marchand, Benoit Barbeau

    Published 2023-09-01
    “…Abstract The recent surge in the use of filtering facepiece respirators (FFRs) during the SARS-CoV-2 pandemic triggered economic and environmental concerns with regards to their safe reuse and/or disposal. …”
    Get full text
    Article
  3. 1663

    COVID-19 Mortality in a Pediatric Patient with Hemoglobin SC Disease and Alpha-Thalassemia Trait by Joshua E. Motelow, Stacie Kahn, Patrick T. Wilson

    Published 2021-01-01
    “…He tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by PCR although his hemoglobin level remained near his baseline. …”
    Get full text
    Article
  4. 1664

    COVID-19 and APOL-1 High-Risk Genotype-Associated Collapsing Glomerulonephritis by Sasmit Roy, Srikanth Kunaparaju, Narayana Murty Koduri, Vikram Sangani, Mytri Pokal, Venu Madhav Konala, Mamtha Balla, Sreedhar Adapa

    Published 2021-01-01
    “…Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) primarily affects the lungs and can lead to acute respiratory distress syndrome (ARDS). …”
    Get full text
    Article
  5. 1665

    A review of research progress on factors influencing death in COVID-19 patients by Wenyuan ZHENG, Jianxiong HU, Jing ZHAO, Zuhua RONG, Guanhao HE, Xing LI, Jianpeng XIAO, Wenjun MA

    Published 2024-10-01
    “…Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an acute respiratory infection. The majority of infected individuals present with either asymptomatic or mild symptoms, such as dry throat, sore throat, cough, and fever. …”
    Get full text
    Article
  6. 1666

    What Signal Paradoxes of Global Economy by T. A. Malova

    Published 2020-07-01
    “…The main paradox of globalization receives an unexpected and dramatic verification by the spread of the SARS-COV-2 virus. Disruption of international communications as the only possible way to combat the spread of infection in the short term contradicts the need to restore its interconnectedness in the long term. …”
    Get full text
    Article
  7. 1667

    Beneficio terapéutico plausible de CIMAvax-EGF® en pacientes con trastornos respiratorios pos-COVID-19 by Héctor José Pérez Hernández

    Published 2024-04-01
    “… El SARS-CoV-2 y sus secuelas se constituyen reto para la salud pública global. …”
    Get full text
    Article
  8. 1668

    Multisystem inflammatory syndrome in children with COVID-19 in a multitransfused patient by Swarnalata Das, Manas Behera Ranjan, Palash Das

    Published 2024-01-01
    “…The child was investigated for MIS-C because of unexpected rise of serum ferritin from 1980 ng/mL (October 2020) to 6686 ng/mL (in January 2021) despite being on regular chelation. Antibody titre for SARS COVID-19 was positive. The patient was treated with intravenous corticosteroids and improved with the same. …”
    Get full text
    Article
  9. 1669

    A Cross-Sectional Study on Side Effects of “Corbevax” Covid-19 Vaccine among 12- to 14-Year Age Group in a Tertiary Care Hospital in Meerut, Uttar Pradesh by Chhaya Mittal, Harimu Bargayary, Mohit Saini

    Published 2025-01-01
    “…Later, the Government of India has approved the usage of Corbevax, a Hyderabad-based biological E SARS-CoV-2 (COVID-19) vaccine among 12- to 14-year age group from March 16, 2022. …”
    Get full text
    Article
  10. 1670

    Jusvinza treatment resolution in confirmed COVID-19 patients. Santiago de Cuba, 2021 by Sandra Caridad Laurencio Vallina, Martha María Arias Carbonell, Leonardo Ramos Hechavarría, Dayami Lescay Balanquet, Roger Pina Núñez

    Published 2024-01-01
    “…<strong>Foundation</strong>: SARS-CoV-2 infection is the most important emerging disease of this century. …”
    Get full text
    Article
  11. 1671
  12. 1672

    Editorial by Jörg Tremmel, Markus Rutsche

    Published 2022-04-01
    “…All experts agree: If mankind had failed to develop vaccines against SARS-CoV-2, the death toll would have been much higher. …”
    Get full text
    Article
  13. 1673

    COVID-19 Vaccine Acceptance among Ajman Undergraduate Dental Students: A Cross-Sectional Study by M. A. Jaber, M. Abdelmagied, E. M. El-Ameen, K. I. Afrashtehfar

    Published 2023-01-01
    “…Achieving widespread coronavirus disease 2019 (COVID-19) vaccination is crucial in controlling the pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This cross-sectional study aimed to identify factors associated with the willingness of dental medicine students to receive the COVID-19 vaccine. …”
    Get full text
    Article
  14. 1674

    Abdominal Pain as First Manifestation of New Coronavirus Infection COVID-19 by M. R. Skhirtladze, A. A. Timofeeva, E. L. Bueverova, M. N. Aladin, R. T. Rzayev

    Published 2020-12-01
    “…The patient was discharged for outpatient care. Patients with SARS-CoV-2 may have abdominal complaints that may require exclusion of an acute surgical pathology. …”
    Get full text
    Article
  15. 1675

    The association between underlying conditions, risk factors, risk markers, and post-COVID conditions ≥6 months after COVID-19: A systematic review by Aisha Hill, Madelon Morford, Sharon Saydah, Pamela Logan, Danielle Raso, Erin C. Stone, Joanna Taliano, Emilia H. Koumans, Olga Varechtchouk

    Published 2024-12-01
    “…Introduction: While various demographic factors and underlying medical conditions are associated with the development of post-COVID conditions within a month after SARS-CoV-2 infection, less is known about factors associated with post-COVID symptoms that persist for 6 months or more. …”
    Get full text
    Article
  16. 1676

    Objective Features of Administrative Offenses under the Article 443 of the Code of Ukraine on Administrative Offenses and Their Impact on the Scope of Powers of the National Police... by V. V. Krykun

    Published 2020-06-01
    “…The author has established the content of a socially dangerous act, which stipulates administrative liability under the Art. 433 of the Code of Ukraine on Administrative Offenses: 1) violation of the rules provided by the Resolution of the Cabinet of Ministers of Ukraine “On the prevention of the spread of an acute respiratory disease COVID-19 caused by the corona virus SARS-CoV-2 on the territory of Ukraine” dated from March 11, 2020 No. 211; 2) violation of the requirements of regulatory acts (orders, instructions, rules, regulations, etc.) of the Ministry of Health, which establish sanitary-hygienic and sanitary-anti-epidemic rules. …”
    Get full text
    Article
  17. 1677

    Atomized Neutrophil Membrane-coated MOF Nanoparticles for Direct Delivery of Dexamethasone for Severe Pneumonia by Yixiao Yang, Lizhen Yan, Han Zhang, Chuanguang Xiao, Kai Wang

    Published 2025-01-01
    “…Background: Dexamethasone has proven life-saving in severe acute respiratory syndrome (SARS) and COVID-19 cases. However, its systemic administration is accompanied by serious side effects. …”
    Get full text
    Article
  18. 1678

    COVID-19 outbreak rates and infection attack rates associated with the workplace: a descriptive epidemiological study by Yiqun Chen, Fu-Meng Khaw, Timothy Aldridge, Claire Ferraro

    Published 2022-07-01
    “…In addition, high outbreak rates in warehouses were observed in the East Midlands and the North West.Conclusions Early identification of geographical regions and industrial sectors with higher rates of COVID-19 workplace outbreaks can inform interventions to limit transmission of SARS-CoV-2.…”
    Get full text
    Article
  19. 1679

    Risk versus Benefit of Using Hydroxychloroquine to Treat Patients with COVID-19 by George G. Zhanel, Michael A. Zhanel, Kevin F. Boreskie, Joseph P. Lynch, James A. Karlowsky

    Published 2021-01-01
    “…Preliminary data indicated that HCQ as well as chloroquine (CQ) possessed in vitro antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Early clinical data from China and France reported that HCQ and CQ were associated with viral load reduction and clinical improvement in patients with COVID-19 compared to control groups; however, an overwhelming number of randomized controlled trials, meta-analyses, and systematic reviews have since concluded that HCQ used alone, or in combination with azithromycin (AZ), provides no mortality or time-to-recovery benefit in hospitalized patients with COVID-19. …”
    Get full text
    Article
  20. 1680

    Cognitive and Emotional Resilience in Parents with Children with Autism Spectrum Disorder During COVID-19: The Role of Promoting Variables by Aziz Sarhani-Robles, María Guillot-Valdés, María Auxiliadora Robles-Bello, David Sánchez-Teruel

    Published 2025-01-01
    “…The methodology employed in this study is as follows: A cross-sectional predictive study was conducted on a sample of 799 parents using an online questionnaire administered during the social confinement resulting from the SARS-CoV-2 pandemic. The information analysed is based on data provided by the parents. …”
    Get full text
    Article